ATE194986T1 - Pyrrolidinyl methyl indol salz - Google Patents

Pyrrolidinyl methyl indol salz

Info

Publication number
ATE194986T1
ATE194986T1 AT96912013T AT96912013T ATE194986T1 AT E194986 T1 ATE194986 T1 AT E194986T1 AT 96912013 T AT96912013 T AT 96912013T AT 96912013 T AT96912013 T AT 96912013T AT E194986 T1 ATE194986 T1 AT E194986T1
Authority
AT
Austria
Prior art keywords
methyl indole
pyrrolidinyl methyl
indole salt
salt
pyrrolidinyl
Prior art date
Application number
AT96912013T
Other languages
English (en)
Inventor
Martin James Wythes
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Application granted granted Critical
Publication of ATE194986T1 publication Critical patent/ATE194986T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT96912013T 1995-05-20 1996-04-10 Pyrrolidinyl methyl indol salz ATE194986T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9510223.2A GB9510223D0 (en) 1995-05-20 1995-05-20 Therapeutic agent
PCT/EP1996/001560 WO1996036632A1 (en) 1995-05-20 1996-04-10 Pyrrolidinyl methyl indole salt

Publications (1)

Publication Number Publication Date
ATE194986T1 true ATE194986T1 (de) 2000-08-15

Family

ID=10774766

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96912013T ATE194986T1 (de) 1995-05-20 1996-04-10 Pyrrolidinyl methyl indol salz

Country Status (41)

Country Link
US (1) US5994387A (de)
EP (1) EP0827503B1 (de)
JP (1) JP3233940B2 (de)
KR (1) KR100295255B1 (de)
CN (1) CN1063175C (de)
AP (1) AP738A (de)
AR (1) AR003949A1 (de)
AT (1) ATE194986T1 (de)
AU (1) AU701154B2 (de)
BG (1) BG63046B1 (de)
BR (1) BR9610858A (de)
CA (1) CA2219631C (de)
CO (1) CO5040221A1 (de)
CZ (1) CZ287939B6 (de)
DE (1) DE69609504T2 (de)
DK (1) DK0827503T3 (de)
DZ (1) DZ2034A1 (de)
ES (1) ES2148753T3 (de)
GB (1) GB9510223D0 (de)
GR (1) GR3034290T3 (de)
HR (1) HRP960223B1 (de)
HU (1) HU217657B (de)
IL (1) IL118239A (de)
IS (1) IS1908B (de)
LV (1) LV11992B (de)
MA (1) MA23876A1 (de)
MX (1) MX9708966A (de)
MY (1) MY132066A (de)
NO (1) NO312068B1 (de)
NZ (1) NZ306448A (de)
OA (1) OA10747A (de)
PL (1) PL183142B1 (de)
PT (1) PT827503E (de)
RU (1) RU2161618C2 (de)
SK (1) SK281782B6 (de)
TN (1) TNSN96074A1 (de)
TR (1) TR199701397T1 (de)
UA (1) UA44320C2 (de)
WO (1) WO1996036632A1 (de)
YU (1) YU29496A (de)
ZA (1) ZA963938B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9825988D0 (en) * 1998-11-27 1999-01-20 Pfizer Ltd Indole derivatives
US20100266638A1 (en) * 2004-02-26 2010-10-21 Allergan, Inc. Headache treatment method
JP2015524400A (ja) * 2012-07-19 2015-08-24 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ９−［４−（３−クロロ−２−フルオロ−フェニルアミノ）−７−メトキシ−キナゾリン−６−イルオキシ］−１，４−ジアザ−スピロ［５．５］ウンデカン−５−オンのフマル酸塩、その薬物としての使用及び調製

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3906406C1 (de) * 1989-03-01 1990-10-25 Goedecke Ag, 1000 Berlin, De
US5545644A (en) * 1990-10-15 1996-08-13 Pfizer Inc. Indole derivatives
HU225055B1 (en) * 1990-10-15 2006-05-29 Pfizer Indole derivatives, their intermediates, process for production them and pharmaceutical compositions containing the compounds
AP486A (en) * 1993-04-27 1996-04-16 Pfizer Indole derivatives.

Also Published As

Publication number Publication date
MY132066A (en) 2007-09-28
IL118239A (en) 2000-10-31
LV11992A (lv) 1998-03-20
AP738A (en) 1999-03-23
KR100295255B1 (ko) 2001-08-07
UA44320C2 (uk) 2002-02-15
IS1908B (is) 2003-12-31
CZ364897A3 (cs) 1998-11-11
HK1017884A1 (en) 1999-12-03
IL118239A0 (en) 1996-09-12
MA23876A1 (fr) 1996-12-31
BR9610858A (pt) 1999-07-13
ZA963938B (en) 1997-11-17
HRP960223A2 (en) 1997-10-31
DK0827503T3 (da) 2000-11-20
AR003949A1 (es) 1998-09-30
SK281782B6 (sk) 2001-07-10
PL323143A1 (en) 1998-03-16
CO5040221A1 (es) 2001-05-29
RU2161618C2 (ru) 2001-01-10
CA2219631C (en) 2001-01-23
JPH10506639A (ja) 1998-06-30
GB9510223D0 (en) 1995-07-19
EP0827503B1 (de) 2000-07-26
US5994387A (en) 1999-11-30
PL183142B1 (pl) 2002-05-31
HUP9801761A3 (en) 1999-06-28
TNSN96074A1 (fr) 2005-03-15
HU217657B (hu) 2000-03-28
NO975210D0 (no) 1997-11-13
ES2148753T3 (es) 2000-10-16
NZ306448A (en) 1998-10-28
BG63046B1 (bg) 2001-02-28
KR19990014934A (ko) 1999-02-25
LV11992B (en) 1998-06-20
HRP960223B1 (en) 2000-12-31
GR3034290T3 (en) 2000-12-29
PT827503E (pt) 2000-11-30
DE69609504D1 (de) 2000-08-31
DZ2034A1 (fr) 2002-07-21
BG102053A (en) 1998-06-30
JP3233940B2 (ja) 2001-12-04
DE69609504T2 (de) 2000-12-14
CN1063175C (zh) 2001-03-14
OA10747A (en) 2002-12-11
HUP9801761A2 (hu) 1999-05-28
CZ287939B6 (cs) 2001-03-14
SK154197A3 (en) 1999-01-11
WO1996036632A1 (en) 1996-11-21
AP9600801A0 (en) 1996-04-30
MX9708966A (es) 1998-03-31
YU29496A (sh) 1998-12-23
AU5500596A (en) 1996-11-29
IS4605A (is) 1997-10-30
NO975210L (no) 1997-11-13
NO312068B1 (no) 2002-03-11
EP0827503A1 (de) 1998-03-11
AU701154B2 (en) 1999-01-21
CN1185152A (zh) 1998-06-17
CA2219631A1 (en) 1996-11-21
TR199701397T1 (xx) 1998-03-21

Similar Documents

Publication Publication Date Title
FI931558A7 (fi) Indolin johdannaisia
FI970800L (fi) Migreeninvastaisia indolijohdossuoloja
FI972275L (fi) Indolijohdannainen
DK43193A (da) Indolderivater
NO961475L (no) Indol-derivater
BR9606743A (pt) Derivados indol úteis no tratamento de osteoporose
FI951546L (fi) Parantunut indolin biosynteesi
FI950568L (fi) 5-heteroaryyli-indolijohdannaiset
PT1189583E (pt) Derivados de indol
FI961844L (fi) Fenyyli-indoliyhdisteitä
PT1228041E (pt) Derivados de indol
FI962496A7 (fi) 3-substituoidut 1-aryyli-indoliyhdisteet
DE69609504D1 (de) Pyrrolidinyl methyl indol salz
FI971492L (fi) Indolijohdannaiset 5-HT1-tyyppisinä agonisteina
DK0725061T3 (da) Substituerede indolderivater
ATE241615T1 (de) 5-heteroaryl-substituierte indole
NO975811D0 (no) Ny anvendelse for pyrrolderivater
FI951047A7 (fi) Menetelmä indolijohdannaisten valmistamiseksi
SI0827503T1 (en) Pyrrolidinyl methyl indole salt
DE59605373D1 (de) Substituierte Indol-Derivate
HK1017884B (en) Pyrrolidinyl methyl indole salt
GB9523097D0 (en) Indole derivatives
BR9509331A (pt) Diluente de esperma compreendendo um derivado de indol
ITMI951687A0 (it) Composti indolici
ITMI950030A0 (it) Composti indolici

Legal Events

Date Code Title Description
REN Ceased due to non-payment of the annual fee